Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors
โ Scribed by B. Frankel; Sharon L. Longo; Timothy C. Ryken
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 172 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0001-6322
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Objective. To examine the expression of FasIFas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage. Methods. Normal and OA human knee cartilage and cells isolated from these tissues were
Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
Fas (Apo-1, CD95), a member of the nerve growth factor/tumour necrosis factor receptor superfamily, mediates apoptosis in response to agonistic antibodies or Fas ligand (Fas-L) binding. Fas has been shown to be present on hepatocyte membranes in normal liver and in chronic hepatitis C. At the presen